Discovery in Our Labs
The Winthrop P. Rockefeller Cancer Institute directs cancer research for the University of Arkansas for Medical Sciences (UAMS) and its affiliated institutions. Cancer Institute scientists are committed to reducing cancer incidence, mortality and morbidity in Arkansas and the surrounding region.
The Cancer Institute accomplishes its goals through focused research programs, shared resources and multidisciplinary disease-specific committees.
The Cancer Institute’s approach is simple: Discovery in our labs leads to the development of new treatment strategies, which are then delivered to the patients in our clinics. The bottom line for our patients is that our research fuels innovative treatment options.Our Research
Research Programs
All research at the Cancer Institute is organized into four distinct research programs to maximize and nurture scientific collaborations and productivity.
Learn More
Clinical Research
Clinical research conducted at the Cancer Institute focuses on cancer prevention, screening, treatment and support.
Learn More
Shared Resources
Shared resources provide Cancer Institute members with cost-effective access to specialized technologies, methodologies and quality control.
Learn More
Education
Numerous educational and training opportunities are available for cancer researchers from the Cancer Institute, the Translational Research Institute and UAMS Research Administrati
Learn More
Internal Funding
Internal funds available to support cancer research are updated monthly.
Learn More
Membership
The mission of the Winthrop P. Rockefeller Cancer Institute is to translate today’s discoveries into tomorrow’s strategies to effectively reduce cancer throughout its continuum fr
Learn MoreResearch: NIH Awards UAMS’ Nakagawa $3.6 Million to Expand HPV Cancer Vaccine Study
Mayumi Nakagawa, M.D., Ph.D., was awarded $3.6 million from the National Cancer Institute (NCI) to complete phase 2 clinical trials of PepCan, a breakthrough vaccine she developed at UAMS to treat cancers caused by human papillomavirus (HPV).
More News
UAMS Researcher Leading $3.1 Million Preschool Intervention to Reduce Obesity and Cancer in Arkansas, Louisiana
UAMS is leading a major new effort to reduce cancer by addressing eating habits in early childcare and education settings. The project, led by UAMS’ Taren Swindle, Ph.D., will reach about 5,000 children and 500 teachers across Arkansas and Louisiana.
Read more
Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team
LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…
Read more
UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer
LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…
Read more
Jenkins to Help Lead Clinical Trials Expansion at UAMS Winthrop P. Rockefeller Cancer Institute
LITTLE ROCK — Amy Jo Jenkins, M.S., CCRP, recently joined the Winthrop P. Rockefeller Cancer Institute’s new Office of Clinical Trials Administration and will lead the Early Phase Clinical Trials at the University of Arkansas for Medical Sciences (UAMS).
Read moreWant to read more stories like these?